Lord Abbett Developing Growth P (LADPX)
17.10
+0.63 (+3.83%)
USD |
May 27 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 1.13% | 2.863B | 0.00% | 102.0% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -588.13M | -32.20% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks long-term growth of capital through a diversified and actively managed portfolio consisting of developing growth companies, many of which are traded over the counter. The fund invests in equity securities of companies that the portfolio management team believes demonstrate above-average, long-term growth potential. Under normal conditions, the fund invests at least 65% of its net assets in equity securities of small companies. It may invest up to 10% of its net assets in securities of foreign companies, including emerging market companies, American Depositary Receipts ("ADRs"), and other similar depositary receipts. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | LAGWX |
| Equity Style | Small Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Small Growth |
| Category Index | Russell 2000 Growth TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Lord Abbett |
| Prospectus Benchmark Index | |
| Russell 2000 Growth TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| F. O’Halloran | 20.34 yrs |
| Matthew DeCicco | 4.42 yrs |
| Vernon Bice | 3.42 yrs |
| Benjamin Ebel | 1.63 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
92
-588.13M
-2.609B
Category Low
1.147B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2022
Performance Versus Category
As of May 27, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 27, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Inspire Medical Systems Inc | 2.38% | 183.92 | 2.75% |
| Intra-Cellular Therapies Inc | 2.37% | 58.28 | -0.75% |
| iRhythm Technologies Inc | 2.09% | 140.61 | 2.98% |
| Evoqua Water Technologies Corp | 2.09% | 36.37 | 1.82% |
| Endava PLC ADR | 2.04% | 105.02 | 14.28% |
| Semtech Corp | 1.98% | 64.28 | 2.78% |
| Rapid7 Inc | 1.91% | 73.92 | 4.78% |
| Diodes Inc | 1.86% | 77.39 | 4.71% |
| Calix Inc | 1.81% | 37.81 | 3.17% |
| ShockWave Medical Inc | 1.75% | 174.33 | 3.36% |
Basic Info
| Investment Strategy | |
| The investment seeks long-term growth of capital through a diversified and actively managed portfolio consisting of developing growth companies, many of which are traded over the counter. The fund invests in equity securities of companies that the portfolio management team believes demonstrate above-average, long-term growth potential. Under normal conditions, the fund invests at least 65% of its net assets in equity securities of small companies. It may invest up to 10% of its net assets in securities of foreign companies, including emerging market companies, American Depositary Receipts ("ADRs"), and other similar depositary receipts. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | LAGWX |
| Equity Style | Small Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Small Growth |
| Category Index | Russell 2000 Growth TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Lord Abbett |
| Prospectus Benchmark Index | |
| Russell 2000 Growth TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| F. O’Halloran | 20.34 yrs |
| Matthew DeCicco | 4.42 yrs |
| Vernon Bice | 3.42 yrs |
| Benjamin Ebel | 1.63 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-27-22) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield (5-24-22) | Upgrade |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 21.16 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of March 31, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 1/5/1998 |
| Last Annual Report Date | 7/31/2021 |
| Last Prospectus Date | 12/1/2021 |
| Share Classes | |
| LADCX | C |
| LADFX | Other |
| LADQX | Retirement |
| LADRX | Retirement |
| LADSX | Retirement |
| LADTX | Retirement |
| LADVX | Retirement |
| LADYX | Inst |
| LAGWX | A |
| LOGWX | Other |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |